Table 4 Neonatal factors associated with mother-to-child transmission of HIV
From: Mother-to-child transmission of human immunodeficiency virus in aten years period
VARIABLES | With | Without | P* | RR | IC 95% | ||
|---|---|---|---|---|---|---|---|
N | % | n | % | ||||
Birth weight | 0.0270 | ||||||
≥ 2500 g | 8 | 2.8 | 301 | 97.2 | 1.00 | ||
< 2500 g | 7 | 8.0 | 80 | 92 | 3.11 | 1.16-8.33 | |
Birth Weight in comparison to gestational age (GA) | 0.0110 | ||||||
Adequate forGA | 10 | 2.9 | 332 | 97.1 | 1.00 | ||
Small for GA | 5 | 13.2 | 33 | 86.8 | 4.50 | 1.62-12.48 | |
Oral AZT | 0.0010 | ||||||
Yes | 11 | 2.8 | 381 | 97.2 | 1.00 | ||
No | 2 | 100 | 0 | 0 | 35.64 | 19.90-63.81 | |
Neonatal pathology | 0.0047 | ||||||
Yes | 5 | 14.7 | 29 | 85.3 | 5.67 | 2.01-15.96 | |
No | 9 | 2.6 | 338 | 97.4 | 1.00 | ||
Congenital Toxoplasmosis | < 0.0001 | ||||||
Yes | 4 | 66.7 | 2 | 33.3 | 23.94 | 10.63-53.93 | |
No | 11 | 2.8 | 384 | 97.2 | 1.00 | ||
Pneumonia | 0.0076 | ||||||
Yes | 3 | 25.0 | 9 | 75 | 8.10 | 2.63-25.02 | |
No | 12 | 3.1 | 377 | 97.9 | 1.00 | ||
Congenital CMV | 0.0075 | ||||||
Yes | 2 | 50.0 | 2 | 50 | 15.27 | 5.00-46.63 | |
No | 13 | 3.3 | 384 | 96.7 | 1.00 | ||
Hepatitis B | 1.0000 | ||||||
Yes | 0 | 0.0 | 4 | 100 | NC | ||
No | 15 | 3.8 | 382 | 96.2 | |||
Syphilis | 1.0000 | NC | |||||
Yes | 0 | 0.0 | 2 | 100 | |||
No | 15 | 3.8 | 384 | 96.2 | |||
Anemia (hb < 13,5 g/dl) | 0.0051 | ||||||
Yes | 8 | 8.7 | 84 | 91.3 | 5.83 | 1.58-21.46 | |
No | 3 | 1.5 | 198 | 98.5 | 1.00 | ||
IUGR (intra uterine growth restriction) | 0.0470 | ||||||
Yes | 3 | 12.5 | 21 | 87.5 | 4.18 | 1.25-14.00 | |
No | 11 | 3.0 | 357 | 97 | 1.00 | ||
Hepatitis C | 1.0000 | ||||||
Yes | 0 | 0.0 | 10 | 100 | NC | ||
No | 15 | 3.8 | 376 | 96.2 | |||